CLINICAL_TRIALS
trial_result
· 2024-12-27
Clinical Trial Update: Study of Romiplostim for Chemotherapy Induced Thrombocytopenia [Phase 2]
Summary
Phase 2 trial of romiplostim for chemotherapy-induced thrombocytopenia has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Isolated Chemotherapy-induced Thrombocytopenia | Phase 2 | Status: COMPLETED | Results posted: 2024-12-27